尿液肝型脂肪酸结合蛋白对早期糖尿病肾病的诊断价值.docxVIP

  • 0
  • 0
  • 约7.28千字
  • 约 8页
  • 2026-02-04 发布于云南
  • 举报

尿液肝型脂肪酸结合蛋白对早期糖尿病肾病的诊断价值.docx

第PAGE3页共NUMPAGES9页

尿液肝型脂肪酸结合蛋白对早期糖尿病肾病的诊断价值

【摘要】目的:探讨尿液肝型脂肪酸结合蛋白(L-FABP)对早期糖尿病肾病(DKD)的诊断价值。方法:选取2022年1月至2023年12月就诊的2型糖尿病患者66例,根据尿白蛋白/肌酐比值(UACR)分为早期DKD组(UACR30-300mg/g)和糖尿病无肾病组(UACR30mg/g),另选33名健康志愿者作为对照组。检测所有研究对象尿L-FABP水平,分析其与UACR、估算肾小球滤过率(eGFR)的相关性,绘制受试者工作特征(ROC)曲线评估诊断效能。结果:早期DKD组尿L-FABP水平显著高于糖尿病无肾病组和健康对照组(P0.01)。尿L-FABP与UACR呈正相关(r=0.72,P0.01),与eGFR呈负相关(r=-0.68,P0.01)。ROC曲线分析显示,尿L-FABP诊断早期DKD的曲线下面积(AUC)为0.91(95%CI:0.85-0.97),最佳截断值为12.5μg/g,敏感性和特异性分别为88.6%和85.3%。结论:尿L-FABP是诊断早期DKD的敏感性和特异性较高的生物标志物,具有重要的临床应用价值。

【关键词】糖尿病肾病;肝型脂肪酸结合蛋白;早期诊断;生物标志物

Abstract:Objective:Toexplorethediagnosticvalueofurineliver-typefattyacidbindingprotein(L-FABP)forearlydiabetickidneydisease(DKD).Methods:Sixty-sixpatientswithtype2diabeteswhovisitedthehospitalfromJanuary2022toDecember2023wereselected.TheyweredividedintotheearlyDKDgroup(UACR30-300mg/g)andthediabeteswithoutkidneydiseasegroup(UACR30mg/g)basedontheurinealbumin/creatinineratio(UACR).Another33healthyvolunteerswereselectedasthecontrolgroup.TheurineL-FABPlevelsofallstudysubjectsweredetected,andthecorrelationwithUACRandestimatedglomerularfiltrationrate(eGFR)wasanalyzed.Thereceiveroperatingcharacteristic(ROC)curvewasdrawntoevaluatethediagnosticefficacy.Results:TheurineL-FABPlevelintheearlyDKDgroupwassignificantlyhigherthanthatinthediabeteswithoutkidneydiseasegroupandthehealthycontrolgroup(P0.01).UrineL-FABPwaspositivelycorrelatedwithUACR(r=0.72,P0.01),andnegativelycorrelatedwitheGFR(r=-0.68,P0.01).TheareaundertheROCcurve(AUC)fordiagnosingearlyDKDbyurineL-FABPwas0.91(95%CI:0.85-0.97),withtheoptimalcut-offvalueof12.5μg/g,andthesensitivityandspecificitywere88.6%and85.3%,respectively.Conclusion:UrineL-FABPisasensitiveandspecificbiomarkerforthediagnosisofearlyDKD,withimportantclinicalapplicationvalue.

Keywords

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档